CS
Cannell & Spears Portfolio holdings
AUM
$4.95B
This Quarter Return
+2.66%
1 Year Return
+21.47%
3 Year Return
+82.49%
5 Year Return
+137.04%
10 Year Return
+287.57%
AUM
$836M
AUM Growth
+$836M
(+3.9%)
Cap. Flow
+$14.2M
Cap. Flow
% of AUM
1.7%
Top 10 Holdings %
Top 10 Hldgs %
43.35%
Holding
157
New
12
Increased
21
Reduced
29
Closed
4
Top Buys
| 1 |
Mattel
MAT
|
$15.1M |
| 2 |
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
|
$6.48M |
| 3 |
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
|
$5.86M |
| 4 |
Comcast
CMCSA
|
$2.77M |
| 5 |
Brighthouse Financial
BHF
|
$2.37M |
Top Sells
| 1 |
Apple
AAPL
|
$9.61M |
| 2 |
Johnson Controls International
JCI
|
$8.29M |
| 3 |
Kellanova
K
|
$621K |
| 4 |
Aptiv
APTV
|
$560K |
| 5 |
CELG
Celgene Corp
CELG
|
$535K |
Sector Composition
| 1 | Financials | 24.82% |
| 2 | Healthcare | 19.1% |
| 3 | Technology | 15.01% |
| 4 | Consumer Discretionary | 12.22% |
| 5 | Industrials | 11.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Fortive
FTV
$16.2B
| $11M | 1.32% |
155,638
-862
| -0.6% | -$61K |
|
27
Johnson & Johnson
JNJ
$427B
| $6.68M | 0.8% |
51,399
| – | – |
|
|
RDS.B
28
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $6.48M | 0.77% |
+103,550
| New | +$6.48M |
|
|
RDS.A
29
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $5.86M | 0.7% |
+96,701
| New | +$5.86M |
|
30
UnitedHealth
UNH
$281B
| $5.16M | 0.62% |
26,354
+3,591
| +16% | +$703K |
|
31
AXIS Capital
AXS
$7.71B
| $4.09M | 0.49% |
71,414
-2,109
| -3% | -$121K |
|
32
Adient
ADNT
$2.01B
| $3.77M | 0.45% |
44,859
+19,548
| +77% | +$1.64M |
|
33
SPDR S&P 500 ETF Trust
SPY
$658B
| $3.53M | 0.42% |
14,067
-459
| -3% | -$115K |
|
34
Aon
AON
$79.1B
| $2.93M | 0.35% |
20,041
| – | – |
|
35
Union Bankshares
UNB
$119M
| $2.87M | 0.34% |
59,357
| – | – |
|
36
Exxon Mobil
XOM
$487B
| $2.8M | 0.33% |
34,123
-11
| -0% | -$902 |
|
|
37
Johnson Controls International
JCI
$69.9B
| $2.68M | 0.32% |
66,469
-205,754
| -76% | -$8.29M |
|
38
Berkshire Hathaway Class B
BRK.B
$1.09T
| $2.59M | 0.31% |
14,124
| – | – |
|
|
39
Brighthouse Financial
BHF
$2.7B
| $2.37M | 0.28% |
+38,951
| New | +$2.37M |
|
40
Biogen
BIIB
$19.4B
| $2.23M | 0.27% |
7,115
| – | – |
|
41
Trimble
TRMB
$19.2B
| $2.04M | 0.24% |
52,000
| – | – |
|
42
Procter & Gamble
PG
$368B
| $1.84M | 0.22% |
20,248
| – | – |
|
43
Wells Fargo
WFC
$263B
| $1.8M | 0.22% |
32,635
| – | – |
|
44
Vanguard Small-Cap Value ETF
VBR
$31.4B
| $1.78M | 0.21% |
13,945
+125
| +0.9% | +$16K |
|
45
Merck
MRK
$210B
| $1.74M | 0.21% |
27,166
+1,080
| +4% | +$69.1K |
|
46
iShares Biotechnology ETF
IBB
$5.6B
| $1.7M | 0.2% |
5,108
+50
| +1% | +$16.7K |
|
47
Kinder Morgan
KMI
$60B
| $1.47M | 0.18% |
76,741
-9,191
| -11% | -$176K |
|
|
48
Berkshire Hathaway Class A
BRK.A
$1.09T
| $1.37M | 0.16% |
5
| – | – |
|
49
iShares Russell 1000 Growth ETF
IWF
$116B
| $1.33M | 0.16% |
10,640
| – | – |
|
50
IBM
IBM
$227B
| $1.24M | 0.15% |
8,517
+3,947
| +86% | +$573K |
|